Securities Code: 300267
Securities Abbreviation: Erkang Pharmaceutical
Announcement Number: 2026-004
Hunan Erkang Pharmaceutical Co., Ltd. announces the pre-disclosure of share reduction by its controlling shareholder, Mr. Shuai Fangwen. Mr. Shuai guarantees that the information provided to the company is true, accurate, and complete, with no false records, misleading statements, or significant omissions. The company and all members of the board guarantee that the announcement content is consistent with the information provided by the information discloser.
Special Reminder: Mr. Shuai Fangwen, the controlling shareholder, holds 853,574,906 shares, accounting for 41.38% of the total share capital of the company. He plans to reduce his shareholding by no more than 42,000,000 shares, or 2.04% of the total share capital, within three months starting from 15 trading days after the announcement date (from April 23, 2026, to July 22, 2026) through centralized bidding or block trading. The total number of shares reduced by the above shareholder through centralized bidding on the stock exchange within any consecutive ninety calendar days shall not exceed 1% of the total shares of the company; the total number of shares reduced through block trading within any consecutive ninety calendar days shall not exceed 2% of the total shares of the company.